glp-1 heart attack The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action New Mechanisms to Prevent Heart

149 85051 Ingolstadt Deutschland [email protected] Anmelden 3 Bewertungen 2

Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback

While many might think of these therapies as an easy fix, in reality, these drugs are not a cure and must be used in conjunction with a healthy diet and exercise

www.statnews.com/2023/11/10/eu-regulator-recommends-diabetes-drug-mounjaros-approval-to-include-obesity/